Skip to main content
Premium Trial:

Request an Annual Quote

PamGene Licenses Microarray Platform to Nottingham University

NEW YORK, July 12 (GenomeWeb News) - PamGene International said today that it has licensed its 3-dimensional, flow-through microarray platform to NottinghamUniversity in England.


According to the company, the service license includes the sale of a PamGene 4-array PamStation and will allow the university to develop multiplex amplifiable probe hybridization as a service on the PamGene platform.


Financial terms of the licensing deal were not disclosed.


PamGene noted that Nottingham University will initially use the PamStation for internal MAPH research, and plans on begin offering services through a company to be spun out of the university's institute of genetics in the near future.


The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.